Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin
Anja Schweizer,1 James E Foley,2 Wolfgang Kothny,2 Bo Ahrén31Novartis Pharma AG, Basel, Switzerland; 2Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA; 3Department of Clinical Sciences, Lund University, Lund, SwedenAbstract: Due to the progressive nature of type 2 diabetes, man...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Dove Medical Press
2013-02-01
|
| Серія: | Vascular Health and Risk Management |
| Онлайн доступ: | http://www.dovepress.com/clinical-evidence-and-mechanistic-basis-for-vildagliptin39s-effect-in--a12220 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|